1251 - 1275 of 9034 Results
Title
Year
-
OPENTitle: Decision making in frontotemporal dementia: neuropsychological and neuroimaging assessmentsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 19Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2025.1632054Best OA location URL: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2025.1632054/pdfCitation Count: 0
-
OPENTitle: Tackling a disease on a global scale, the Global Parkinson’s Genetics Program, GP2: A new generation of opportunitiesJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 112Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ajhg.2025.07.014Best OA location URL: https://www.cell.com/ajhg/pdf/S0002-9297(25)00284-8.pdfCitation Count: 0
- Single-cell transcriptomics for immune profiling of cerebrospinal fluid in neurological diseases2025OPENTitle: Single-cell transcriptomics for immune profiling of cerebrospinal fluid in neurological diseasesJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2025.1599303Best OA location URL: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1599303/pdfCitation Count: 0
-
OPENTitle: An unusual presentation of Huntington’s disease-like syndrome in a patient with Xeroderma pigmentosum type F: Case report and review of the literatureJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100340End Page: 100340Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100340Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100340Citation Count: 0
-
OPENTitle: a-synuclein PET Imaging: From Clinical Utility in Multiple System Atrophy to the Possible Diagnosis of Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 11Start Page: 834End Page: 834Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14110834Best OA location URL: https://www.mdpi.com/2073-4409/14/11/834/pdf?version=1748956205Citation Count: 0
-
OPENTitle: Nigral diffusivity, but not free water, correlates with iron content in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab251Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/4/fcab251/41152899/fcab251.pdfCitation Count: 10
-
OPENTitle: Physics of Protein Aggregation in Normal and Accelerated Brain AgingJournal Name: BioEssaysPublisher: WileyVol: 47Issue #: 8Start Page: e70030End Page: e70030Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/bies.70030Best OA location URL: https://doi.org/10.1002/bies.70030Citation Count: 3
-
OPENTitle: LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic InsightsJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 1Start Page: 169End Page: 169Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3390/cells11010169Best OA location URL: https://www.mdpi.com/2073-4409/11/1/169/pdf?version=1641527866Citation Count: 34
- Intracellular Thermometry at the Micro‐/Nanoscale and its Potential Application to Study Protein Aggregation Related to Neurodegenerative Diseases2020RESTRICTEDTitle: Intracellular Thermometry at the Micro‐/Nanoscale and its Potential Application to Study Protein Aggregation Related to Neurodegenerative DiseasesJournal Name: ChemBioChemPublisher: WileyVol: 22Issue #: 9Start Page: 1546End Page: 1558Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cbic.202000765Citation Count: 12
-
OPENTitle: Cholinergic system changes in Parkinson's disease: emerging therapeutic approachesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 4Start Page: 381End Page: 392Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00377-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8985079Citation Count: 220
-
OPENTitle: A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic InflammationJournal Name: DrugsPublisher: Springer Science and Business Media LLCVol: 83Issue #: 5Start Page: 389End Page: 402Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40265-023-01838-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40265-023-01838-z.pdfCitation Count: 32
-
OPENTitle: Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s SymptomsJournal Name: International Journal of Environmental Research and Public HealthPublisher: MDPI AGVol: 19Issue #: 1Start Page: 364End Page: 364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijerph19010364Best OA location URL: https://www.mdpi.com/1660-4601/19/1/364/pdf?version=1641285359Citation Count: 67
-
OPENTitle: Clearing the Smoke: What Protects Smokers from Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 2Start Page: 267End Page: 272Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29707Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29707Citation Count: 21
-
OPENTitle: Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as BiomarkersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 669End Page: 683Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28941Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28941Citation Count: 78
-
OPENTitle: Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network ApproachJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 8Start Page: 1511End Page: 1527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30231Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30231Citation Count: 0
-
OPENTitle: Constructing and exploring neuroimaging projects: a survey from clinical practice to scientific researchJournal Name: Insights into ImagingPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 272End Page: 272Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13244-024-01848-9Best OA location URL: https://insightsimaging.springeropen.com/counter/pdf/10.1186/s13244-024-01848-9Citation Count: 1
-
OPENTitle: Transcriptional landscape of human microglia implicates age, sex, and APOE‐related immunometabolic pathway perturbationsJournal Name: Aging CellPublisher: WileyVol: 21Issue #: 5Start Page: e13606End Page: e13606Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13606Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13606Citation Count: 52
-
OPENTitle: Radioligands Targeting the Purinergic P2X ReceptorsJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 13Start Page: 984End Page: 984Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14130984Best OA location URL: https://www.mdpi.com/2073-4409/14/13/984/pdf?version=1751010309Citation Count: 0
- Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease2022RESTRICTEDTitle: Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s diseaseJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 22Issue #: 6Start Page: 489End Page: 498Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2022.2091436Citation Count: 15
-
OPENTitle: Therapeutic potential of autophagy-enhancing agents in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0154-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0154-3Citation Count: 266
-
OPENTitle: Public Engagement and Neurology: An UpdateJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 4Start Page: 429End Page: 429Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11040429Best OA location URL: https://www.mdpi.com/2076-3425/11/4/429/pdf?version=1617937511Citation Count: 7
-
OPENTitle: Initiation and propagation of α-synuclein aggregation in the nervous systemJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 19End Page: 19Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00368-6Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00368-6Citation Count: 245
-
OPENTitle: Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and RecommendationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 175End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13586Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9941935Citation Count: 6
- Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment—A scoping review2025RESTRICTEDTitle: Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment—A scoping reviewJournal Name: Pharmacological ReviewsPublisher: Elsevier BVVol: 78Issue #: 1Start Page: 100094End Page: 100094Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmr.2025.100094Citation Count: 0
- Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective2022OPENTitle: Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspectiveJournal Name: Animal Models and Experimental MedicinePublisher: WileyVol: 5Issue #: 1Start Page: 27End Page: 37Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ame2.12209Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ame2.12209Citation Count: 26